Pfizer Inc
NYSE: PFE
$28.84
-$0.09 (-0.3%)
Closing Price on October 22, 2024
PFE Articles
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the price appears to be more finite. We have heard enough names around this diabetes treatment...
Published:
Last Updated:
China’s PMI indicates a considerable slowing of its economy. (Reuters) Senior EC and ECB officials warn that the eurozone is on the brink of a calamity. (Reuters) Problems at Research In Motion...
Published:
The 10-year Treasury hit yet another record low under 1.6% today and stocks are in the tank again due to poor economic data. Europe continues to face a meltdown and the hope is for a rate cut out...
Published:
Last Updated:
A stock market that sells off eight of nine days is not a good market. Even the Facebook IPO is being viewed as a one-off item rather than a systemic item which will make the market stronger. ...
Published:
Last Updated:
The energy sector saw a lot of activity from short sellers in April, but other stocks saw some action as well. We’ve already covered some of the bigger names here and some of the cult stocks here....
Published:
Last Updated:
Sony (NYSE: SNE) says it will return to profit and will cut its TV unit losses in half. (Reuters) Cisco Systems (NASDAQ: CSCO) warns about the economy as it releases earnings. (Reuters) Regulators...
Published:
Blame whatever you want. A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and Greece, a weaker BRIC and emerging market story, commodity prices and on and...
Published:
Last Updated:
Moody’s warns that Japan’s finances will be hurt if it cannot get acceptance of a new sales tax. (Reuters) New Chinese factory data indicate that the industry’s activity may have bottomed....
Published:
The major US stock indexes opened flat this morning but started to move higher following the better-than-expected ISM report on manufacturing (our coverage here). Construction spending in the US was...
Published:
Last Updated:
Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Canaccord also reiterated its buy rating on Watson Pharmaceuticals (WPI: NYSE)...
Published:
The major US stock indexes opened slightly lower this morning and continued drifting lower all day. The Chicago PMI report got the day started on the wrong foot, showing a decline in spending even...
Published:
Last Updated:
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the biggest public merger rumors out there. At least that is the belief of Wall...
Published:
Last Updated:
How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as “Who knows, but we can make it one more!” J&J has joined the...
Published:
Last Updated:
Dividends have continued to rise. Better yet, they are expected to keep rising for the rest of the year. A study from Dow Jones Indexes showed a rise of almost 2.2% so far this year from the 30...
Published:
Last Updated:
Nestle to buy Pfizer’s (NYSE: PFE) baby food operation for $11.9 billion. (Reuters) China’s factory output rises slightly in March, but still not at levels of expansion. (Reuters) Vodafone...
Published: